CUE icon

Cue Biopharma

89 hedge funds and large institutions have $216M invested in Cue Biopharma in 2021 Q2 according to their latest regulatory filings, with 10 funds opening new positions, 29 increasing their positions, 32 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

more funds holding

Funds holding:

more funds holding in top 10

Funds holding in top 10:

more first-time investments, than exits

New positions opened: | Existing positions closed:

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

2.67% less ownership

Funds ownership: 61.78%59.11% (-2.7%)

6% less capital invested

Capital invested by funds: $229M → $216M (-$13.5M)

52% less call options, than puts

Call options by funds: $814K | Put options by funds: $1.68M

Holders
89
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$814K
Puts
$1.68M
Net Calls
Net Calls Change

Top Buyers

1 +$5.41M
2 +$4.27M
3 +$1.76M
4
Morgan Stanley
Morgan Stanley
New York
+$1.26M
5
BL
Bleichroeder LP
New York
+$1.17M

Top Sellers

1 -$12.4M
2 -$2.42M
3 -$1.43M
4
SMH
Sanders Morris Harris
Texas
-$1.17M
5
BlackRock
BlackRock
New York
-$1.15M
Name Holding Trade Value Shares
Change
Change in
Stake
26
$1.12M
27
$968K
28
$952K
29
$940K
30
$768K
31
$728K
32
$704K
33
$612K
34
$559K
35
$526K
36
$478K
37
$416K
38
$408K
39
$407K
40
$389K
41
$370K
42
$369K
43
$361K
44
$350K
45
$331K
46
$316K
47
$316K
48
$315K
49
$304K
50
$299K